[Retracted] Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments

Table 2

Baseline characteristics of patients undergoing radiofrequency ablation, surgical resection, or liver transplantation in the unweighted and weighted study population.

	Unweighted cohort					Weighted cohort
	Resection	Live transplantation	RFA	P	SMD	Resection	Live transplantation	RFA	P	SMD
	472	259	524			1060.73	934	1080.03
Age (mean (SD))	62.79 (11.23)	56.85 (7.42)	62.80 (9.27)	<0.001	0.445	61.64 (10.38)	59.38 (7.74)	61.99 (9.19)	0.005	0.196
Sex = male (%)	355 (75.2)	208 (80.3)	406 (77.5)	0.286	0.082	806.7 (76.1)	737.1 (78.9)	830.5 (76.9)	0.778	0.046
stage (%)				<0.001	0.588				0.531	0.122
T1a	47 (10.0)	94 (36.3)	128 (24.4)			206.1 (19.4)	220.3 (23.6)	238.6 (22.1)
T1b	312 (66.1)	141 (54.4)	375 (71.6)			706.1 (66.6)	607.9 (65.1)	743.0 (68.8)
T2	113 (23.9)	24 (9.3)	21 (4.0)			148.5 (14.0)	105.9 (11.3)	98.5 (9.1)
Race (%)				<0.001	0.345				0.651	0.106
Black	58 (12.3)	17 (6.6)	65 (12.4)			117.5 (11.1)	92.2 (9.9)	116.6 (10.8)
Other	158 (33.5)	42 (16.2)	116 (22.1)			292.0 (27.5)	200.3 (21.4)	260.4 (24.1)
White	256 (54.2)	200 (77.2)	343 (65.5)			651.1 (61.4)	641.5 (68.7)	703.1 (65.1)
Grade (%)				<0.001	0.956				0.108	0.212
Well differentiated	86 (18.2)	64 (24.7)	87 (16.6)			211.4 (19.9)	175.8 (18.8)	207.6 (19.2)
Moderately differentiated	245 (51.9)	96 (37.1)	79 (15.1)			400.3 (37.7)	307.6 (32.9)	348.4 (32.3)
Poorly differentiated	98 (20.8)	32 (12.4)	25 (4.8)			153.4 (14.5)	108.2 (11.6)	86.2 (8.0)
Unknown	43 (9.1)	67 (25.9)	333 (63.5)			295.6 (27.9)	342.4 (36.7)	437.7 (40.5)
Tumor size (mean (SD))	58.29 (43.14)	27.86 (14.33)	31.13 (14.85)	<0.001	0.671	42.99 (34.07)	32.49 (15.33)	34.86 (19.15)	<0.001	0.276
Fibrosis score = F1 (%)	225 (47.7)	221 (85.3)	427 (81.5)	<0.001	0.576	701.0 (66.1)	726.3 (77.8)	813.2 (75.3)	0.021	0.174
Lymph node involvement = yes (%)	4 (0.8)	2 (0.8)	6 (1.1)	0.84	0.026	7.3 (0.7)	4.1 (0.4)	15.3 (1.4)	0.28	0.069